These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23527135)
1. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients. Charpentier C; Champenois K; Gervais A; Landman R; Joly V; Le Gac S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D; Yazdanpanah Y PLoS One; 2013; 8(3):e59205. PubMed ID: 23527135 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings. Dobseu R; Nanfack A; Kowo M; Ambada G; Kamgaing R; Chenwi C; Fainguem N; Ka'e A; Ngangoum E; Sosso S; Tchiegang C; Ndjolo A BMC Infect Dis; 2020 Oct; 20(1):758. PubMed ID: 33059627 [TBL] [Abstract][Full Text] [Related]
3. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels. Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K; J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732 [TBL] [Abstract][Full Text] [Related]
4. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study. Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C; BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711 [TBL] [Abstract][Full Text] [Related]
5. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers. Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133 [TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693 [TBL] [Abstract][Full Text] [Related]
8. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3. Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772 [TBL] [Abstract][Full Text] [Related]
9. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients. Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966 [TBL] [Abstract][Full Text] [Related]
10. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937 [TBL] [Abstract][Full Text] [Related]
11. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. Nunes D; Fleming C; Offner G; O'Brien M; Tumilty S; Fix O; Heeren T; Koziel M; Graham C; Craven DE; Stuver S; Horsburgh CR J Acquir Immune Defic Syndr; 2005 Dec; 40(5):538-44. PubMed ID: 16284529 [TBL] [Abstract][Full Text] [Related]
12. Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis. Afify SM; Tabll A; Nawara HM; El Kassas M; Elfert A; Seno M; El-Kousy S Clin Lab; 2018 Oct; 64(10):1685-1693. PubMed ID: 30336529 [TBL] [Abstract][Full Text] [Related]
13. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring. Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964 [TBL] [Abstract][Full Text] [Related]
14. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index. Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB; PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666 [TBL] [Abstract][Full Text] [Related]
16. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals. Chen X; Liu X; Duan S; Tang R; Zhou S; Ye R; Yang Y; Wang J; Yao S; He N Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348839 [TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of liver fibrosis in patients with HIV/chronic hepatitis C co-infection in different ethnic groups. Sarsekeyeva N; Kosherova B; Azizov I J Infect Dev Ctries; 2016 Oct; 10(10):1099-1107. PubMed ID: 27801373 [TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657 [TBL] [Abstract][Full Text] [Related]
19. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients. Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826 [TBL] [Abstract][Full Text] [Related]
20. Causative factors of liver fibrosis in HIV-infected patients. A single center study. Androutsakos T; Schina M; Pouliakis A; Kontos A; Sipsas N; Hatzis G BMC Gastroenterol; 2020 Apr; 20(1):91. PubMed ID: 32252653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]